Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.

Petrone P, Sarkisyan G, Fernández M, Coloma E, Akopian G, Ortega A, Kaufman HS.

Arch Surg. 2011 Apr;146(4):444-7. doi: 10.1001/archsurg.2011.55.

PMID:
21502453
2.

Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome?

Stoicescu A, Andrei M, Becheanu G, Stoicescu M, Nicolaie T, Diculescu M.

Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):766-72.

PMID:
23272525
3.

A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.

Zhao J, Zheng X, Chu H, Zhao J, Cong Y, Fried M, Fox M, Dai N.

Neurogastroenterol Motil. 2014 Jun;26(6):794-802. doi: 10.1111/nmo.12331. Epub 2014 Mar 18.

4.

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin.

Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A.

World J Gastroenterol. 2009 Jun 7;15(21):2628-31.

5.

Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.

Ghoshal UC, Srivastava D, Ghoshal U, Misra A.

Eur J Gastroenterol Hepatol. 2014 Jul;26(7):753-60. doi: 10.1097/MEG.0000000000000122.

PMID:
24849768
6.

Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?

Reddymasu SC, Sostarich S, McCallum RW.

BMC Gastroenterol. 2010 Feb 22;10:23. doi: 10.1186/1471-230X-10-23.

7.

Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth.

Majewski M, Reddymasu SC, Sostarich S, Foran P, McCallum RW.

Am J Med Sci. 2007 May;333(5):266-70.

PMID:
17505166
9.

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.

Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M.

Gut. 2007 Jun;56(6):802-8. Epub 2006 Dec 5.

10.

Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution.

Parodi A, Dulbecco P, Savarino E, Giannini EG, Bodini G, Corbo M, Isola L, De Conca S, Marabotto E, Savarino V.

J Clin Gastroenterol. 2009 Nov-Dec;43(10):962-6. doi: 10.1097/MCG.0b013e3181a099a5.

PMID:
19525858
11.

Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.

Roland BC, Ciarleglio MM, Clarke JO, Semler JR, Tomakin E, Mullin GE, Pasricha PJ.

J Clin Gastroenterol. 2015 Aug;49(7):571-6. doi: 10.1097/MCG.0000000000000257.

PMID:
25319735
12.

Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: a retrospective study of 932 patients.

Schatz RA, Zhang Q, Lodhia N, Shuster J, Toskes PP, Moshiree B.

World J Gastroenterol. 2015 Apr 21;21(15):4574-82. doi: 10.3748/wjg.v21.i15.4574.

13.

Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.

Moraru IG, Moraru AG, Andrei M, Iordache T, Drug V, Diculescu M, Portincasa P, Dumitrascu DL.

Rom J Intern Med. 2014;52(3):143-50.

PMID:
25509557
14.

Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome.

Scarpellini E, Giorgio V, Gabrielli M, Filoni S, Vitale G, Tortora A, Ojetti V, Gigante G, Fundarò C, Gasbarrini A.

Eur Rev Med Pharmacol Sci. 2013 May;17(10):1314-20.

15.

Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.

Moraru IG, Portincasa P, Moraru AG, Diculescu M, Dumitraşcu DL.

Rom J Intern Med. 2013 Jul-Dec;51(3-4):143-7.

PMID:
24620626
16.

Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.

Rana SV, Sharma S, Kaur J, Sinha SK, Singh K.

Digestion. 2012;85(3):243-7. doi: 10.1159/000336174. Epub 2012 Mar 30.

PMID:
22472730
17.

Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan.

Yakoob J, Abbas Z, Khan R, Hamid S, Awan S, Jafri W.

Saudi J Gastroenterol. 2011 Nov-Dec;17(6):371-5. doi: 10.4103/1319-3767.87176.

18.

Small intestinal bacterial overgrowth as an uncommon cause of false positive lactose hydrogen breath test among patients with diarrhea-predominant irritable bowel syndrome in Asia.

Wang Y, Xiong L, Gong X, Li W, Zhang X, Chen M.

J Gastroenterol Hepatol. 2015 Jun;30(6):995-1000. doi: 10.1111/jgh.12862.

PMID:
25470082
19.

Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.

Esposito I, de Leone A, Di Gregorio G, Giaquinto S, de Magistris L, Ferrieri A, Riegler G.

World J Gastroenterol. 2007 Dec 7;13(45):6016-21.

20.

Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.

Lombardo L, Foti M, Ruggia O, Chiecchio A.

Clin Gastroenterol Hepatol. 2010 Jun;8(6):504-8. doi: 10.1016/j.cgh.2009.12.022. Epub 2010 Jan 6.

PMID:
20060064
Items per page

Supplemental Content

Write to the Help Desk